Similar long-term efficacy of dual therapy containing raltegravir and a boosted protease inhibitor versus standard triple therapies in pretreated HIV-1-infected patients in a retrospective, real-life cohort of 14 years

HIV Medicine ◽  
2018 ◽  
Vol 19 (9) ◽  
pp. 662-667
Author(s):  
I Krznaric ◽  
M Bickel ◽  
A Carganico ◽  
P De Leuw ◽  
A Haberl ◽  
...  
Keyword(s):  
Protease Inhibitor ◽  
Real Life ◽  
Dual Therapy ◽  
Term Efficacy ◽  
Hiv 1

Long-Term Efficacy and Safety of Tipranavir Boosted With Ritonavir in HIV-1-Infected Patients Failing Multiple Protease Inhibitor Regimens

2007 ◽  
Vol 45 (4) ◽  
pp. 401-410 ◽  
Author(s):  
Martin Markowitz ◽  
Leonard N Slater ◽  
Robert Schwartz ◽  
Powel H Kazanjian ◽  
Bruce Hathaway ◽  
...  
Keyword(s):  
Protease Inhibitor ◽  
Efficacy And Safety ◽  
Term Efficacy ◽  
Hiv 1

Long-term efficacy and safety of etravirine-containing regimens in a real-life cohort of treatment-experienced HIV-1-infected patients

2016 ◽  
Vol 48 (5) ◽  
pp. 392-398 ◽  
Author(s):  
Clotilde Allavena ◽  
Christine Katlama ◽  
Laurent Cotte ◽  
Pierre Marie Roger ◽  
Pierre Delobel ◽  
...  
Keyword(s):  
Real Life ◽  
Efficacy And Safety ◽  
Term Efficacy ◽  
Hiv 1

scholarly journals Long-term efficacy and safety of atazanavir/ritonavir treatment in a real-life cohort of treatment-experienced HIV patients

2010 ◽  
Vol 13 ◽  
pp. P31-P31 ◽  
Author(s):  
K Jansen ◽  
A Sönnerborg ◽  
P Pugliese ◽  
S Biguenet ◽  
JL Eychenne ◽  
...  
Keyword(s):  
Real Life ◽  
Efficacy And Safety ◽  
Hiv Patients ◽  
Term Efficacy

Lack of impact of protease inhibitor resistance-associated mutations on the outcome of HIV-1-infected patients switching to darunavir-based dual therapy

2019 ◽  
Vol 52 (3) ◽  
pp. 202-206
Author(s):  
Pilar Vizcarra ◽  
José L. Blanco ◽  
Rocío Montejano ◽  
Eugenia Negredo ◽  
Nuria Espinosa ◽  
...  
Keyword(s):  
Protease Inhibitor ◽  
Dual Therapy ◽  
Protease Inhibitor Resistance ◽  
Inhibitor Resistance ◽  
Hiv 1

Dual Therapy With Lamivudine + Protease Inhibitor During Pregnancy for Prevention of Mother-to-Child Transmission of HIV-1

2013 ◽  
Vol 63 (5) ◽  
pp. e159-e163 ◽  
Author(s):  
Smaranda S. Gliga ◽  
Cyril O. Clavel ◽  
Anne F. Alix ◽  
Marc A. Dommergues ◽  
Frederique Quetin ◽  
...  
Keyword(s):  
Protease Inhibitor ◽  
Dual Therapy ◽  
Mother To Child Transmission ◽  
Child Transmission ◽  
Mother To Child ◽  
Hiv 1

Long-term follow-up of 11 protease inhibitor (PI)-naïve and PI-treated HIV-infected patients harbouring virus with insertions in the HIV-1 protease gene

HIV Medicine ◽  
2010 ◽  
Vol 12 (3) ◽  
pp. 138-144 ◽  
Author(s):  
C Amiel ◽  
C Charpentier ◽  
N Désiré ◽  
P Bonnard ◽  
M-G Lebrette ◽  
...  
Keyword(s):  
Protease Inhibitor ◽  
Protease Gene ◽  
Long Term Follow Up ◽  
Hiv 1

Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents

The Lancet ◽  
2003 ◽  
Vol 362 (9401) ◽  
pp. 2045-2051 ◽  
Author(s):  
Chang-Heok Soh ◽  
James M Oleske ◽  
Michael T Brady ◽  
Stephen A Spector ◽  
William Borkowsky ◽  
...  
Keyword(s):  
T Cell ◽  
Combination Therapy ◽  
Protease Inhibitor ◽  
Children And Adolescents ◽  
Cd4 T Cell ◽  
Long Term Effects ◽  
Cell Recovery ◽  
Hiv 1

887 EAU REAL-LIFE DATA REGISTRY: LONG-TERM EFFICACY AND SAFETY OF TRANSURETHRAL NEEDLE ABLATION (TUNA@) IN OVER 500 MEN WITH LUTS/BPH

2010 ◽  
Vol 9 (2) ◽  
pp. 280 ◽  
Author(s):  
A. Tubaro ◽  
K. Hoefner ◽  
H. Villavicencio ◽  
J.J. De La Rosette ◽  
C.R. Chappie
Keyword(s):  
Real Life ◽  
Efficacy And Safety ◽  
Life Data ◽  
Term Efficacy ◽  
Data Registry ◽  
Real Life Data
Sign in / Sign up

Export Citation Format

Share Document